Show simple item record

dc.contributor.authorParker, Cen_US
dc.coverage.spatialEnglanden_US
dc.date.accessioned2019-06-24T09:43:54Z
dc.date.issued2018en_US
dc.identifierhttps://www.ncbi.nlm.nih.gov/pubmed/30430023en_US
dc.identifieresmoopen-2018-000451en_US
dc.identifier.citationESMO Open, 2018, 3 (6), pp. e000451 - ?en_US
dc.identifier.issn2059-7029en_US
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/3275
dc.identifier.doi10.1136/esmoopen-2018-000451en_US
dc.format.extente000451 - ?en_US
dc.languageengen_US
dc.language.isoengen_US
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/en_US
dc.subjectpodcasten_US
dc.titleReport from the ESMO 2018 presidential symposium-Radiotherapy to the primary tumour for men with newly diagnosed metastatic prostate cancer: survival results from STAMPEDE.en_US
dc.typeOther
rioxxterms.versionofrecord10.1136/esmoopen-2018-000451en_US
rioxxterms.licenseref.startdate2018en_US
rioxxterms.typeotheren_US
dc.relation.isPartOfESMO Openen_US
pubs.issue6en_US
pubs.notesNot knownen_US
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/Royal Marsden Clinical Units
pubs.publication-statusPublished onlineen_US
pubs.volume3en_US
pubs.embargo.termsNot knownen_US
dc.contributor.icrauthorParker, Chrisen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

http://creativecommons.org/licenses/by/4.0/
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by/4.0/